A study published in the New England Journal of Medicine found that the weight loss injection liraglutide, branded as Saxenda, effectively reduced body mass index (BMI) in children aged 6-11. The study involved 82 children who were randomly allocated to receive either the liraglutide injection or a placebo plus lifestyle intervention. The children in the liraglutide group saw a BMI reduction of at least 5% in 46% of participants, compared to only 9% in the placebo group. The researchers concluded that liraglutide was more effective than lifestyle interventions in reducing BMI in children.
Source link
Liraglutide: Weight loss injection is effective in children aged 6-11, study reports
